Advocate for patients to have access to medicines and health services globally
Healthcare, Biotech, & Public Service Leader:
Born in Mexico with a rare and debilitating bleeding disorder, Guadalupe nearly died at twelve because of limited access to medicines. One night, his appendix burst, and he began bleeding internally, requiring emergency surgery. In search of better medication to stop the bleeding, Guadalupe was rushed to a hospital eight hours away. He bled so severely during the surgery that his heart stopped beating, and the doctors declared him clinically dead. But against all odds, Guadalupe survived.
After his recovery, his family and he migrated to the U.S., searching for better healthcare for him. The transition was difficult: his parents arrived in California with little money or education, and Guadalupe spoke no English. Navigating the health care system as an immigrant and not knowing the language was a challenge. Accessing treatment and services for his disease was practically impossible at first. The nearest specialist was one hr and a half away. Thankfully, he gained access to care and treatment with help from the Hemophilia Association chapter in the area. Driven by his experiences, Guadalupe made it his mission to fight for justice and equity in the healthcare system.
Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.
Guadalupe's mission is to build a world where no one is without the medical treatment they need to survive and thrive. Justice and equity are his core values. Both arise from his own experience as a person who has, in many ways, lived on the margins. He seeks to serve as a catalyst for change and innovation for biopharmaceuticals, hospitals, clinics, government, and non-profits.
Guided by his comprehensive healthcare experience and the better to achieve his life goal of expanding access to medical treatment globally, he founded and serve as CEO of Healr Solutions, a company engineering technology to solve the most pressing issues in supply chains in the biopharmaceutical industry.
As a provider of services and medicines, Guadalupe led the global departments at top biotech firms (Ultragenyx, Biogen, Amgen, and GSK) in supply chain, manufacturing, sourcing, packaging, logistics, and distribution of medicines to 98 countries, supplying millions of people with treatments. He ran the most extensive free healthcare system in the United States (UCLA Health), providing 30,000 underserved patients free healthcare and medicine. Guadalupe also assisted in developing and implementing the Affordable Care Act (Obama Care) that provided healthcare access to 20 million people in the United States (RAND Corporation). In addition to his corporate roles, he researched the development of new medications at MIT with Moderna's founder, Professor Bob Langer.
As a healthcare expert, Guadalupe has been featured in the Boston Globe, Business Insider, STAT News, MIT Technology Review, Los Angeles Business Journal, and Boston Business Journal. He has spoken at events and conferences at MIT, Harvard, and UPenn, and has testified before the United States House of Representatives and Senate.
Public Service & Boards.........
Governor Charlie Baker appointed him to the Massachusetts Rare Disease Advisory Council to provide direction for the Governor, the Legislature, and the Department of Public Health on addressing rare disease policy and actions in the State of Massachusetts.
The MIT PKG Public Service Center named him a Practioner-in-Residence, teaching MIT students through seminars, lectures, and mentorship about public service. MIT and the MIT Alumni Association awarded him the prestigious Margaret L.A. MacVicar Award in 2021.
Guadalupe received a BS in Chemistry, an MS in Engineering Systems, and an MBA from the Massachusetts Institute of Technology (MIT). He obtained a Master of Public Policy in Healthcare from Georgetown, and he is pursuing a Master of Public Administration in Government and Politics at Harvard.
6 Powerful LGBTQ+ Executives on corporate boards - Business Insider, 2021.
John F. Kennedy Fellowship - Harvard University, 2022.
100 Most Inspiring People in the Life Science Industry - PharmaVoice, 2020.
40 under 40 - Boston Business Journal, 2019.
Healthcare Executive of the Year - Los Angeles Business Journal, 2013.
Board of Directors
Advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. Focuses on LGBTQIA+, BIPOC, and other underserved groups to enable local, national, and global neighbors to flourish.
Rare Disease Advisory Council
Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in the State of Massachusetts
Save One Life
Board of Directors
Empowers individuals and families affected by bleeding disorders in developing countries through direct financial assistance and access to medical treatment.
MIT LBGT+ Alumni Association
Board of Directors
Fosters a social and professional network for Massachusetts Institute of Technology alumni in order to increase diversity and community within MIT and society as a whole.